Michael H. Davidson - 09 Jun 2022 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Issuer symbol
TENX
Transactions as of
09 Jun 2022
Transactions value $
$0
Form type
4
Filing time
10 Jun 2022, 20:45:01 UTC
Previous filing
12 Jan 2022
Next filing
25 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TENX Common Stock 609K 09 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TENX Stock Option (right to buy) Award $0 +5K $0.00 5K 09 Jun 2022 Common Stock 5K $0.62 Direct
holding TENX Stock Option (right to buy) 6.25K 09 Jun 2022 Common Stock 6.25K $2.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 15, 2021, the Reporting Person mistakenly filed a Form 4 reporting an aggregate beneficial ownership of 606,645, instead of 608,645 as reflected in the current filing.